Global Tissue Diagnostics Market 2022-2028

December 2022 | 76 pages | ID: G25ED3843592EN
Gen Consulting Company

Abstracts

Tissue diagnostics is analyzing and evaluating particular tissue samples in order to understand the biological background of illnesses. The test is widely used in the medical field to analyze a tissue sample for diagnosis of cancer and other disorders. The global tissue diagnostics market is likely to register a CAGR of over 6.7% with an incremental growth of USD 2.6 billion during the forecast period 2022-2028.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global tissue diagnostics market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the tissue diagnostics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, application, end user, and region. The global market for tissue diagnostics can be segmented by technology: immunohistochemistry, in situ hybridization, primary and special staining, digital pathology and workflow, anatomic pathology. Among these, the immunohistochemistry segment was accounted for the highest revenue generator in 2021. Tissue diagnostics market is further segmented by application: breast cancer, prostate cancer, gastric cancer, non-small cell lung cancer, others. The breast cancer segment is estimated to account for the largest share of the global tissue diagnostics market. Based on end user, the tissue diagnostics market is segmented into: hospitals, research laboratories, pharmaceutical organizations, contract research organizations (CROS), others. The hospitals segment held the largest share of the global tissue diagnostics market in 2021 and is anticipated to hold its share during the forecast period. On the basis of region, the tissue diagnostics market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. In 2021, North America made up the largest share of revenue generated by the tissue diagnostics market.

Market Segmentation

By technology: immunohistochemistry, in situ hybridization, primary and special staining, digital pathology and workflow, anatomic pathology

By application: breast cancer, prostate cancer, gastric cancer, non-small cell lung cancer, others

By end user: hospitals, research laboratories, pharmaceutical organizations, contract research organizations (CROS), others

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The market research report covers the analysis of key stake holders of the global tissue diagnostics market. Some of the leading players profiled in the report include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson & Company (BD), bioMerieux SA, Danaher Corporation, Merck KGaA, Qiagen N.V., Roche Holding AG, Siemen Healthineers AG, Thermo Fisher Scientific Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global tissue diagnostics market.
• To classify and forecast the global tissue diagnostics market based on technology, application, end user, region.
• To identify drivers and challenges for the global tissue diagnostics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global tissue diagnostics market.
• To identify and analyze the profile of leading players operating in the global tissue diagnostics market.

Why Choose This Report

• Gain a reliable outlook of the global tissue diagnostics market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY TECHNOLOGY

Immunohistochemistry
In situ hybridization
Primary and special staining
Digital pathology and workflow
Anatomic pathology

PART 6. MARKET BREAKDOWN BY APPLICATION

Breast cancer
Prostate cancer
Gastric cancer
Non-small cell lung cancer
Others

PART 7. MARKET BREAKDOWN BY END USER

Hospitals
Research laboratories
Pharmaceutical organizations
Contract research organizations (CROS)
Others

PART 8. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 9. KEY COMPANIES

Abbott Laboratories
Agilent Technologies, Inc.
Becton, Dickinson & Company (BD)
bioMerieux SA
Danaher Corporation
Merck KGaA
Qiagen N.V.
Roche Holding AG
Siemen Healthineers AG
Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER